Mayflower Financial Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Mayflower Financial Advisors, LLC

$629 Million
Q3 2024

A detailed history of Mayflower Financial Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 1,482 shares of VRTX stock, worth $588,754. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,482

Previous 729,312 99.8%

Holding current value

$588,754

Previous $342 Million 99.8%

% of portfolio

0.11%

Previous 26.25%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$460.0 - $505.78 $335 Million - $368 Million	-727,830 Reduced 99.8%	1,482 $689,000
Q2 2024 Aug 02, 2024	BUY	$392.81 - $485.53 $67,956 - $83,996	173 Added 0.02%	729,312 $342 Million
Q1 2024 Apr 29, 2024	BUY	$407.69 - $446.08 $11,007 - $12,044	27 Added 0.0%	729,139 $305 Million
Q4 2023 Jan 22, 2024	SELL	$343.0 - $410.68 $7,889 - $9,445	-23 Reduced -0.0%	729,112 $297 Million
Q3 2023 Oct 12, 2023	SELL	$338.18 - $362.46 $143,726 - $154,045	-425 Reduced 0.06%	729,135 $254 Million
Q2 2023 Jul 13, 2023	BUY	$314.42 - $351.91 $1,572 - $1,759	5 Added 0.0%	729,560 $257 Million
Q1 2023 Apr 12, 2023	BUY	$283.23 - $323.1 $23,508 - $26,817	83 Added 0.01%	729,555 $230 Million
Q4 2022 Jan 25, 2023	BUY	$285.76 - $321.48 $208 Million - $235 Million	729,472 New	729,472 $0
Q3 2022 Oct 19, 2022	BUY	$273.83 - $305.53 $199 Million - $223 Million	728,380 Added 56993.74%	729,658 $1.22 Million
Q3 2022 Oct 17, 2022	SELL	$273.83 - $305.53 $260 Million - $290 Million	-949,397 Reduced 99.87%	1,278 $370,000
Q2 2022 Jul 15, 2022	BUY	$234.96 - $292.55 $7,518 - $9,361	32 Added 0.0%	950,675 $1.14 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $86.5 Million - $102 Million	390,581 Added 69.74%	950,643 $1.12 Million
Q4 2021 Jan 21, 2022	BUY	$177.01 - $223.45 $44,429 - $56,085	251 Added 0.04%	560,062 $664,000
Q3 2021 Oct 26, 2021	BUY	$181.39 - $202.99 $2,539 - $2,841	14 Added 0.0%	559,811 $601,000
Q2 2021 Jul 29, 2021	SELL	$187.49 - $221.1 $11,249 - $13,266	-60 Reduced 0.01%	559,797 $602,000
Q1 2021 Apr 23, 2021	BUY	$207.02 - $241.31 $116 Million - $135 Million	559,857 New	559,857 $618,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.

Account

Mayflower Financial Advisors, LLC Vertex Pharmaceuticals Inc Transaction History